PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jcardisresGuide for AuthorsAbout this journalExplore this journalJournal of Cardiovascular Disease Research
 
J Cardiovasc Dis Res. 2010 Jan-Mar; 1(1): 37–39.
PMCID: PMC3004170

Hydrogen Sulfide—a potent multichannel anti-arrhythmic drug

Abstract

—Arrhythmia is a big headache for cardiologist for a long time. A new antiarrythmic drug with good effects and few side effects should be explored. Hydrogen sulfide, a newly found gaseous transmitter, was found to have multi-effects on a variety of ion channels. It may be a promising antiarrythmic drug. This article reviews the different effects of hydrogen sulfide on different ion channels.

Ion channels initiate and conduct electrical activity in the heart. The channels open and close in response to changes in membrane potential, and allow ionic permeation across the plasma membrane. The idea that defective ion channels might be responsible for cardiac arrhythmia has received indirect support from the anti- or proarrhythmic actions of a host of drugs and toxins that are specific for Na+, Ca2+ and K+ channels. With the progress of the clinical trials, it is widely understood that drugs having multi-effects on various ion channels may be the promising antiarrhythmic drug

Antiarrhythmic drugs today

Recently, cardiologists are more interested in devices and ablation techniques for arrhythmia treatment than in pharmacological treatment. However, pharmacological treatment is still very important especially in prevention of atrial fibrillation and sudden cardiac death.

It is well known that present antiarrhythmic drugs are not ideal. They induce another arrhythmia when treating one arrhythmia or increased the total death rate although inhibited arrhythmia. Therefore, new antiarrhythmic drugs are still welcome.

To date, the most popular antiarrhythmic drug classification is the system developed by Singh and Vaughan Williams1 in the early 1970s and subsequently modified by Singh and Hauswirth and by Harrison.2 In this system, antiarrhythmic drugs were divided into class I for sodium-channel blockade (with subclasses IA, IB and IC), class II for adrenergic antagonism, class III for action-potential prolongation, and class IV for calcium-channel blockade. Among these drugs, since the publication of studies demonstrating that certain drugs may increase mortality in highrisk post-infarction patients,3 basic science and clinical studies have focused on Class III antiarrhythmic drugs. However, Class III drugs prolong repolarization and cardiac refractoriness, and are sometimes associated with potentially lethal Torsades de pointes. Amiodarone, a multichannel blocker, may be the exception to this observation. Therefore, both cardiologists and pharmacologists are turning their interests towards developing new multichannel blocker, since amiodarone nevertheless fails to reduce total mortality compared with placebo in high-risk patients following myocardial infarction.4

Hydrogen sulfide—a potent multichannel acting antiarrhythmic drug -

Recent studies5,6 showed that hydrogen sulfide (H2S), new gaseous transmitter, acted on several cardiac ion channels, inhibited arrhythmia and prevented ischemia-reperfusion injury. It is reasonable to think of it as a potent promising multichannel acting antiarrhythmic drug.

H2S has been best known for decades as the toxic gas or ‘gas of rotten eggs’. It has been founded as a new gaseous transmitter only in recent years.7 And from 2003, H2S has been widely studied in different pathological animals. Most of these studies showed that H2S exerts its function through acting on different ion channels.8,9

Effects of H2S on ATP dependent potassium channel (KATP)

The first study10 about the action of H2S on ion channels was from Zhao’s study, and they studied the effects of H2S on KATP. They proved the opening effect of H2S on KATP channel through three different levels. First, they found blood pressure decreasing effect of H2S was antagonized by blockade of KATP channels. Then their results showed H2S relaxed rat aortic in vitro in a KATP channel-dependent manner. Finally, they proved with patch clamp technique that H2S increased KATP channel currents. After that, Geng et al11 found H2S has negative inotropic effect through opening KATP channel. Zhang and colleagues5 did an even more interesting study. They made an ischemia-reperfusion model in vitro by Langendorff apparatus. They found H2S had a cardioprotective effect against ischemia-reperfusion injury. Moreover, they found H2S decreased arrhythmia score significantly in this model. Through patch-clamp technique, they also found that cardioprotective mechanism of H2S was opening of KATP channel. Zhang’s results challenged the traditional point of view, i.e. shortening of repolarization of cardiac cells due to opening of potassium channel may shorten the refractory period and induce arrhythmia. This may be explained by the following mechanisms: 1) Although H2S shortened refractory period of ventricular myocardial cells, it prolonged the effective refractory period relatively; 2) H2S has greater effects on other ion channels.

To further explore the mechanism of H2S on KATP, Zhang et al.12 studied the effect of H2 S on gene and protein expression of KATP (SUR2B mRNA and Kir 6.1mRNA). Their results showed that H2S increased the gene expression of KATP as well as the protein expression.

Effects of H2S on Calcium channel

The first study that may involve L-Calcium channel is from Geng’s work.11 Both in vivo and in vitro experiments in this study proved that H2S had a negative inotropic effect on rat heart. This may suggest the effect of H2S on L-calcium channel, although the authors did not perform any related experiments.

As researchers focused on the effect of H2S on KATP channel, Xiao et al13 noticed another channel—L-calcium channel was also involved in the acting mechanism of H2S. They studied the effect of H2S on the functional curve of baroreflex. The results showed H2S facilitated the carotid sinus baroreceptor. Pretreatment with a KATP channel blocker, abolished the above effects while pretreatment with Bay K8644 (an agonist of calcium channels) eliminated the effect of H2S on carotid sinus baroreceptor. Therefore, they concluded that H2S opened KATP channels and further closed the calcium channels.

The above study is on carotid sinus baroreceptor, which may be quite different from myocardial cells. Yet, Xu and colleagues14 studied the effect of H2S on L-calcium channel on guinea pig papillary muscles. Their data showed that pretreatment with L-type Ca2+ channel agonist Bay K8644 partially blocked the effects of NaHS (a H2S donor), which suggested that the reduction of calcium influx may also contribute to the effects of H2S. Furthermore, they found that pretreatment with Ca2+ -free K-H solution containing Glibenclamide completely blocked the effects of H2S, which indicated that the effects of H2S guinea pig papillary are due to the changes of potassium and calcium currents.

Step further, Sun et al15 studied the effects of H2S on L-Calcium channel directly, and stated definitely that Hydrogen sulphide is an inhibitor of L-type calcium channels. Sun and colleagues found a concentration-dependent inhibition of peak ICa.L on cardiomyocytes by NaHS (a H2S donor). It becomes clear that H2S has an inhibitory effect on L-Calcium channel. However, the mechanism needs further study.

Although, no study was reported about the H2S on T type Calcium channel on cardiomyocytes, Nagasawa et al.16 studied the effect of H2S on T-type calcium channels on NG 108–15 cells (which may be differentiated into neuronal cells). Their study showed H2 S could stimulate the T-type calcium channels. Therefore, it is reasonable to think of H2S as having an effect on T-type calcium channels, which needs further exploration.

Effects of H2S on chloride channel

Chloride channels are important for setting cell resting membrane potential and maintaining proper cell volume. These channels conduct Cl as well as other anions such as HCO3−, I, SCN, and NO3−. Chloride channels display a variety of important physiological and cellular roles that include regulation of pH, volume homeostasis, organic solute transport, cell migration, cell proliferation and differentiation. Recent studies have identified several chloride (Cl) channel genes in the heart, including CFTR, ClC−2, ClC−3, CLCA, Bestrophin, and TMEM16A. It has been shown that Cl channels may contribute to cardiac arrhythmogenesis, myocardial hypertrophy and heart failure, and cardioprotection against ischaemia–reperfusion.17

Since the reason above, we are concerned of the effect of H2S on chloride channel. The effect is reported on June 2009 by Malekova et al.9, where they derived single chloride channels from the rat heart lysosomal vesicles incorporated into a bilayer lipid membrane. Their results showed that H2S inhibited the chloride channels by decreasing the channel open probability in a concentration-dependent manner. Since they incorporated the single chloride channels into the bilayer lipid membrane, they measured the IC50 for tans and the cis sides, respectively and got the different results (42uM vs. 75uM).

Beneficial cardiac effects from H2S

With the results of the famous CAST clinical trial,3 people realized that benefits for the patient’s prognosis is more important than antiarrhythmia itself. So the effect of H2S on the whole heart may be more important.

The effect on the whole heart was first described in Geng’s study18 Their results showed that administration of exogenous H2S effectively protects cardiomyocytes and contractile activity from isoproterenol injury. Then, Zhang et al5 isolated rat heart, then made an ischemia-reperfusion model with langendorff apparatus. The results showed that the treatment of hearts with a H2S donor during reperfusion resulted in a significant improvement in heart function and the arrhythmia scores was also improved. Furthermore, Sivarajah et al.19 found in the ischemia-reperfusion model that the antiapoptotic effect of NaHS (H2S donor) may be in part due to the opening of the putative mitochondrial adenosine triphosphate-sensitive potassium channels.

CONCLUSION

In summary, H2S has various effects on various ion channels from cardiomyocytes. Not only can it improves heart arrhythmia score, but also can protect heart from ischemia-reperfusion injury and has beneficial effects on the heart function. We have reasons to think of it as a promising antiarrhythmic drug. Since it was a newly found endogenous gaseous signaling molecule, the risk, safety issues, dosage, proposed delivery methods and so on are therefore a big field to be explored.

Acknowledgments

This review was supported by the Beijing Natural Science Foundation (7072027); the Beijing Nova Program (2008B62) and National Natural Science Foudation (30971237).

REFERENCES

1. Vaughan WEM. Classification of antidysrhythmic drugs. Pharmacol Ther B. 1975;1(1):115–38. [PubMed]
2. Harrison DC. Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol. 1985;56(1):185–7. [PubMed]
3. Hallstrom A, Friedman L, Denes P, Rizo-Patron C, Morris M. Do arrhythmia patients improve survival by participating in randomized clinical trials?.Observations from the Cardiac Arrhythmia Suppression Trial (CAST)and the Antiarrhythmics Versus Implantable Defibrillators Trial (AVID) Control Clin Trials. 2003;24(3):341–52. [PubMed]
4. Jafri SM, Borzak S, Goldberger J, Gheorghiade M. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial Canadian Amiodarone Myocardial Infarction Trial. Prog Cardiovasc Dis. 1998;41(1):65–70. [PubMed]
5. Zhang Z, Huang H, Liu P, Tang C, Wang J. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening KATP channels. Can J Physiol Pharmacol. 2007;85(12):1248–53. [PubMed]
6. Zhu YZ, Wang ZJ, Ho P, et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats .J Appl Physiol. 2007;102(1):261–8. [PubMed]
7. Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter [PubMed]
8. Tang G, Wu L, Liang W, Wang R. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005;68(6):1757–64. [PubMed]
9. Malekova L, Krizanova O, Ondrias K. H(2)S and HS(-) donor NaHS inhibits intracellular chloride channels. Gen Physiol Biophys. 2009;28(2):190–4. [PubMed]
10. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J. 2001;20(21):6008–16. [PubMed]
11. Geng B, Yang J, Qi Y, et al. H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 2004;313(2):362–8. [PubMed]
12. Zhang RY, Jin HF, Tang CS, Du JB. Effects of Hydrogen Sulf ide on Gene Expression of Adenosine Tr iphospha te - Sensitive Pota ssium Channel of Aortic Vascular SmoothMuscle Cells in Rats? J Appl Clin Pedia tr? 2009;24(1):21–23.
13. Xiao L, Wu YM, Zhang H, Liu YX, He RR. Hydrogen sulfide facilitates carotid sinus baroreflex in anesthetized rats. Acta Pharmacol Sin. 2006;27(3):294–8. [PubMed]
14. Xu M, Wu YM, Li Q, Wang FW, He RR. Electrophysiological effects of hydrogen sulfide on guinea pig papillary muscles in vitro. Sheng Li Xue Bao. 2007;59(2):215–20. [PubMed]
15. Sun YG, Cao YX, Wang WW, Ma SF, Yao T, Zhu YC. Hydrogen sulphide is an inhibitor of L-type calcium channels and mechanical contraction in rat cardiomyocytes. Cardiovasc Res. 2008;79(4):632–41. [PubMed]
16. Nagasawa K, Tarui T, Yoshida S, et al. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108–15 cells: involvement of T-type Ca2+ channels. J Neurochem. 2009;108(3):676–84. [PubMed]
17. Duan D. Phenomics of cardiac chloride channels: the systematic study of chloride channel function in the heart. J Physiol. 2009;587:2163–77. (Pt 10) [PubMed]
18. Geng B, Chang L, Pan C, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun. 2004;318(3):756–63. [PubMed]
19. Sivarajah A, Collino M, Yasin M, et al. Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock. 2009;31(3):267–74. [PubMed]

Articles from Journal of Cardiovascular Disease Research are provided here courtesy of Elsevier